Most Read Articles
5 days ago
In patients with type 2 diabetes, obesity may be protective against vision-threatening diabetic retinopathy, a recent Korea study has shown.
Roshini Claire Anthony, 4 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

07 Jun 2019
Low-dose aspirin therapy does not confer significant benefits to elderly patients with hypertension, but treatment appears to increase the risk of haemorrhagic events, suggest a Japan study.
4 days ago
The use of opioids may have limited long-term efficacy in the management of chronic noncancer pain, reports a new study.

Acceptance-and-commitment therapy acceptable among advanced cancer patients

05 Jan 2019

Among advanced cancer patients, engagement and satisfaction with acceptance-and-commitment therapy (ACT) appears to be high, according to a new study, which also reports the feasibility of a subsequent trial comparing ACT with talking controls (TC).

Researchers performed a feasibility two-arm randomized controlled trial involving 42 patients with advanced cancer, of whom 20 received ACT while 22 were designated as TC. Study outcomes included the feasibility of recruitment, patient retention, and participant attitudes toward the therapy and outcome measures.

In the overall sample, the most common malignancy was breast cancer, diagnosed in 48 percent (n=20). The average age was 62±11.5 years, and majority of the patients were female (74 percent; n=31). Researchers reported recruiting 78 percent of their target, indicating acceptable feasibility. Main barriers included availability of therapists and definitions of participant eligibility.

In comparison, only 43 percent (n=18) of the initial sample were available for data collection at the 3-month follow-up. This proportion was lower than the 60 percent retention target. Reasons for attrition included death, loss to follow-up and decline in patient health.

In terms of attitude, 62 percent (n=26) of the participants attended at least seven sessions and were identified as mostly or fully engaged with the intervention. Moreover, of those who were followed-up at 3 months, 83 percent and 50 percent of the ACT and TC groups, respectively, found the interventions useful.

The present findings indicate that ACT is an acceptable intervention in patients in palliative care, said researchers. To improve feasibility, future efforts should focus on cutting the burden of research.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
In patients with type 2 diabetes, obesity may be protective against vision-threatening diabetic retinopathy, a recent Korea study has shown.
Roshini Claire Anthony, 4 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

07 Jun 2019
Low-dose aspirin therapy does not confer significant benefits to elderly patients with hypertension, but treatment appears to increase the risk of haemorrhagic events, suggest a Japan study.
4 days ago
The use of opioids may have limited long-term efficacy in the management of chronic noncancer pain, reports a new study.